What smart money is saying about Terns Pharmaceuticals, Inc.
TERN
No fund has written a full thesis on Terns Pharmaceuticals, Inc. in our archive, but 1 fund letter reports a position in it — most recently Baron Health Care Fund in June 2026.
Get an email when a fund writes about it
1
Reported positions
0
Bought
1
Sold
1
Letter
Position history
Every position in Terns Pharmaceuticals, Inc. on record in the archive was reported in Q2 2026, across 1 fund letter — 1 trimmed or exited.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 0 | 1 | 0 |
Fund activity · 1 position · 1 move
- ExitedBaron Health Care FundJune 2026
“Top net sales for the quarter Net Amount Sold ($M) AstraZeneca PLC 3.0 Ionis Pharmaceuticals, Inc. 2.3 Apogee Therapeutics, Inc. 2.0 Terns Pharmaceuticals, Inc. 1.8 Stryker Corporation 1.7 We reduced our positions in AstraZeneca PLC and Ionis Pharmaceuticals, Inc. due to valuation. We sold Apogee Therapeutics, Inc. and Terns Pharmaceuticals, Inc. following announcements that they were being acquired, Apogee by AbbVie Inc. and Terns by Merck & Co., Inc. , another Fund holding .”
Terns Pharmaceuticals, Inc.
Read the letters behind these Terns Pharmaceuticals, Inc. positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger